Intercept does not expect restrictive boxed warning for Ocaliva

(Reuters) - Intercept Pharmaceuticals Inc said its liver drug, Ocaliva, could carry a boxed warning to help ensure proper dosing but does not expect the updated labeling to be restrictive, sending its shares higher.